Advertisement
Home Tags Heart / Stroke-Related: Coronary-Artery Disease

Tag: Heart / Stroke-Related: Coronary-Artery Disease

Review Compares Diagnostic Strategies for Assessment of Coronary Artery Disease

0

Risk for cardiovascular death and myocardial infarction similar for CCTA and ICA; risk reduced with CCTA compared with exercise ECG, SPECT-MPI

Colchicine Tied to Lower Incidence of TJA in Coronary Artery Disease

0

Lower incidence of total knee replacement, total hip replacement seen with use of colchicine 0.5 mg daily

Five-Year Composite Outcome Similar for TiNO-Coated Stent, Everolimus-Eluting Stents

0

In patients with acute coronary syndrome, decrease seen in cardiac death, MI, stent thrombosis with TiNO-coated stent, which was offset by increase in target lesion revascularization

Long-Term Outcomes Similar for Bioresorbable Vascular Scaffolds Versus Metal Stents

0

Increased events seen through three-year follow-up, but similar event rates observed between three and five years

Women Have About 12-Year Delay in Onset of Atherosclerosis

0

Women with highest atherosclerotic burden have higher risk for MACE than men, especially postmenopausal women

Poor-Quality Diet Tied to Higher Risk for Adverse CAD, PAD Outcomes

0

Patients with coronary artery disease or peripheral artery disease with poor diet had higher risks for major adverse cardiovascular and limb events

Meditation Complements Cardiac Rehab for Coronary Artery Disease Patients

0

Benefits include reduction in stress, anxiety, and depression levels, as well as increases in quality of life

MI Risk Increased With Subclinical, Obstructive Coronary Atherosclerosis

0

Highest risk for myocardial infarction seen for those with obstructive-extensive, obstructive-nonextensive subclinical coronary atherosclerosis

History of Adverse Pregnancy Outcomes Linked to Coronary Artery Disease

0

History of gestational hypertension and preeclampsia both associated with increased prevalence of all outcomes

ACC: Treat-to-Target LDL-C Strategy Noninferior to High-Intensity Statins

0

Strategy noninferior for three-year composite of death, myocardial infarction, stroke, or coronary revascularization